Kammerle Schneider is the leader of PATH’s Malaria and Neglected Tropical Diseases program and the director of PATH’s Center for Malaria Control and Elimination. Building on our unparalleled portfolio of malaria tools, approaches, and expertise, she directs our work to eliminate and ultimately eradicate both Plasmodium falciparum and Plasmodium vivax malaria. She also oversees part of a coordinated global effort to stamp out 17 neglected tropical diseases, including onchocerciasis and soil-transmitted helminths.
Kammerle joined PATH in 2011 as a senior policy officer for PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) and then took on the role of deputy director of the program. She also served as deputy director of PATH’s Center for Malaria Control and Elimination, which encompasses the entirety of PATH’s work in malaria—from insecticide-treated bednets to groundbreaking vaccines to improved diagnostics and drug treatments. During this time, she worked extensively to help build the malaria portfolio and to oversee MACEPA’s policy and analytics team. She was responsible for analyzing and influencing changes in policy, strategy, and systems to accelerate the introduction and scale up of new tools and approaches for malaria burden reduction and elimination.
Before joining PATH, Kammerle worked with the International AIDS Vaccine Initiative where she managed policy research and advocacy activities to accelerate the development of, and future global access to, a preventive AIDS vaccine. She also served as the assistant director of the Global Health Program at the Council on Foreign Relations.
Kammerle holds a master of international affairs degree from Columbia University and a bachelor of arts from the University of Washington. She is currently a PhD candidate at the London School of Hygiene & Tropical Medicine.